Biotech researching psychoactive stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
VIEW IN BROWSER
Opportunity Knocks In Neuroscience Stocks: A six month review
Here is a quick glance at neuroscience drug stocks' performance these last few months and what stocks investors should be watching! |
Find out the details
NYU Is Launching $10M Center for Psychoactive Compounds!
New York University wants to expand our minds in a trippy way. |
Find out more
Music And Psilocybin Are Treating Addiction?
Study: Study: When patients trying to quit cigarettes undergo psilocybin treatment, non-classical music has shown to help? |
Read more
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
©2019, All Rights Reserved
|
Unsubscribe
|
View this in Browser
To keep receiving emails from us, please add us to your address book.